Trial Profile
Open label pilot phase II study of STI571 in the treatment of patients with idiopathic hypereosinophilic syndrome (HES) and eosinophilic leukemias
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 18 Nov 2006 New trial record.